Kouzu_2020_Gastric.Cancer_23_356

Reference

Title : Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer - Kouzu_2020_Gastric.Cancer_23_356
Author(s) : Kouzu K , Tsujimoto H , Nishikawa M , Harada M , Sugihara T , Nagata H , Hiraki S , Yaguchi Y , Takahata R , Nomura S , Ito N , Ishibashi Y , Itazaki Y , Tsuchiya S , Hase K , Kishi Y , Ueno H
Ref : Gastric Cancer , 23 :356 , 2020
Abstract :

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) refers to hepatic steatosis caused by something other than alcoholic liver injury, and often occurs after gastrointestinal surgeries such as pancreatoduodenectomy and gastrectomy. This study aimed to identify the risk factors for NAFLD after gastrectomy for gastric cancer. METHODS: A total of 721 patients who underwent gastrectomy for gastric cancer and plane abdominal computed tomography (CT) preoperatively and 1 year after surgery were included in this study. NAFLD was defined as having a mean hepatic CT attenuation value of < 40 Hounsfield units. We retrospectively examined the relationship between the onset of NAFLD and clinicopathological findings to identify the risk factors associated with the development of NAFLD after gastrectomy. RESULTS: The incidence of postoperative NAFLD was 4.85% (35/721). The univariate analysis identified the following factors as being significantly associated with the incidence of NAFLD: age, preoperative BMI >/= 25 kg/m(2), tumor depth of pT3

PubMedSearch : Kouzu_2020_Gastric.Cancer_23_356
PubMedID: 31555950

Related information

Citations formats

Kouzu K, Tsujimoto H, Nishikawa M, Harada M, Sugihara T, Nagata H, Hiraki S, Yaguchi Y, Takahata R, Nomura S, Ito N, Ishibashi Y, Itazaki Y, Tsuchiya S, Hase K, Kishi Y, Ueno H (2020)
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer
Gastric Cancer 23 :356

Kouzu K, Tsujimoto H, Nishikawa M, Harada M, Sugihara T, Nagata H, Hiraki S, Yaguchi Y, Takahata R, Nomura S, Ito N, Ishibashi Y, Itazaki Y, Tsuchiya S, Hase K, Kishi Y, Ueno H (2020)
Gastric Cancer 23 :356